newsfilter
← Latest News
GlobeNewswire·

VectivBio Publishes Invitation to the Annual General Meeting

BASEL, Switzerland, May 10, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG ("VectivBio") (NASDAQ:VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions,